Subscribe To
VIVUS’ QSIVA in Combination with a Digital Lifestyle Intervention Leads to Significant Weight Loss and Decreased Cardiovascular Risk in Patients with Obesity
— Poster presented at the 30th European Congress on Obesity (ECO 2023) shows addition of QSIVA provides benefits compared with Digital Lifestyle Intervention (DLI) alone in improving health outcomes in adults with obesity — AMSTERDAM, Netherlands, May 17, 2023 (GLOBE NEWSWIRE) — VIVUS BV, the European affiliate of VIVUS LLC (“VIVUS”), a biopharmaceutical company, today […] The post VIVUS’ QSIVA in Combination with a Digital Lifestyle Intervention Leads to Significant Weight Loss and Decreased Ca...
Read More
Posted: May 17 2023, 07:30
Author Name: forextv
Views: 110235